Quantcast

Got Stocks from QualityStocks Ones To Watch

Got Stocks

Find out which Small-Cap / Micro-Caps should be on your radar. Get the news and information that moves the markets this week and the "Ones to Watch", only at QualityStocks. The "Quality" is Back in Stocks...




Untitled Document

Ekso Bionics Holdings, Inc. (EKSO)

Ekso Bionics Holdings, Inc. designs, develops, and commercializes exoskeletons, or wearable robots. Exoskeletons are ready-to-wear, battery-powered robots. They are strapped over the user's clothing, enabling individuals to achieve mobility, strength, or endurance not otherwise possible. These have a variety of potential applications in the medical, military, industrial, and consumer markets. The company's lead product is Ekso™. Ekso™ has helped thousands of people living with paralysis take millions of steps not otherwise possible. Ekso Bionics Holdings is based in Richmond, California.

The company's Ekso™ is a robotic exoskeleton used for the rehabilitation of individuals with lower extremity weakness, paralysis or hemiparesis (weakness on one side of the body) owing to such neurological conditions as stroke, spinal cord injury or disease, and traumatic brain injury. Ekso™ is a wearable bionic suit.

Ekso™ enables individuals with any amount of lower extremity weakness to stand up and walk over ground with a natural, full weight bearing, and reciprocal gait. Walking is attained through the user's weight shifts to activate sensors in the device, which initiate steps. Battery-powered motors drive the legs, replacing deficient neuromuscular function.

Ekso Bionics Holdings has been accepted by the Center for Sensorimotor Neural Engineering (CSNE) as an industry partner. Ekso Bionics and CSNE are working jointly to enrich the human machine interface and enhance potential neural interface to create links between the nervous system and the outside world.

Ekso Bionics has been awarded a P20 Exploratory Grant from the National Institutes of Health (NIH). This is to continue the development of an exoskeleton prototype for children. This work will be done in collaboration with the pediatric rehabilitation department at the UCSF Benioff Children's Hospital Oakland. This work will consist of Ekso Bionics developing a pediatric version of its Ekso GT™ robotic exoskeleton.

Ekso GT™ with SmartAssist™ features include the next generation of adaptive assistance software, allowing a greater number of interactive steps; PreGait, a group of early mobilization activities for pre-ambulatory patients preparing for gait therapy; and FreeGait, an advanced mode for patients progressing to community ambulation.

Ekso Bionics announced in January 2015 that nine leading centers in Europe including SPZ Notwill in Switzerland, Institut Guttmann in Spain, and The Clinic for Spinal Cord Injuries in Hornbaek, Denmark (now part of Rigshospitalet and Glostrup Hospital), are participating in a clinical study to include around 70 participants.

The study will examine how Ekso GT may improve general outcomes and reduce secondary complications, including pain and bowel and bladder dysfunction, normally associated with spinal cord injury (SCI). The expectation is that the study will run for 30 months with early findings expected next year.

 

 

 

The QualityStocks
Newsroom

Read the articles covering the biggest movers in the markets today.

Continue

Market
Basics

Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.

Continue

The QualityStocks Daily
Archives

Go back to see our previous newsletters and find out what you might have missed.

Continue